A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma

NCT07869043 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
1100
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer